Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease

Accurate biomarkers of Alzheimer’s disease (AD) are essential for early diagnosis and intervention. Available biomarkers are not sufficient to permit the monitoring of AD progression over time, and additional biomarkers are required. Measures of aggregated amyloid-β (Aβ) could be useful biomarkers f...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksnes, Mari, Tiiman, Ann, Edwin, Trine Holt, Terenius, Lars, Bogdanović, Nenad, Vukojević, Vladana, Knapskog, Anne-Brita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820807/
https://www.ncbi.nlm.nih.gov/pubmed/33488383
http://dx.doi.org/10.3389/fnagi.2020.608628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820807/
https://www.ncbi.nlm.nih.gov/pubmed/33488383
http://dx.doi.org/10.3389/fnagi.2020.608628

Ejemplares similares